Early Experience Using Donor-derived Cell-free DNA for Surveillance of Rejection Following Simultaneous Pancreas and Kidney Transplantation
Sign Up to like & getrecommendations! Published in 2022 at "Transplantation Direct"
DOI: 10.1097/txd.0000000000001321
Abstract: Background. Allograft biopsy is the gold standard for diagnosing graft rejection following simultaneous pancreas and kidney (SPK) transplant. Intraperitoneal biopsies are technically challenging and can be burdensome to patients and the healthcare system. Donor-derived cell-free… read more here.
Keywords: following simultaneous; simultaneous pancreas; surveillance; rejection following ... See more keywords
Do Pretransplant C-Peptide Levels Predict Outcomes Following Simultaneous Pancreas-Kidney Transplantation? A Matched Case-Control Study.
Sign Up to like & getrecommendations! Published in 2021 at "Clinical transplantation"
DOI: 10.1111/ctr.14498
Abstract: Following simultaneous pancreas-kidney transplantation (SPKT), survival outcomes are reported as equivalent in patients with detectable pretransplant C-peptide levels (Cp+) and a "type 2" diabetes mellitus (DM) phenotype compared to type 1 (Cp negative [Cp-]) DM.… read more here.
Keywords: pancreas kidney; following simultaneous; kidney transplantation; case ... See more keywords